Leading the way to safer medication
 Crosscheck  Recommender

Anastrozole

Description

Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor. It inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens. Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women.

ATC Classification

Code
Title
Category
L02BG03
Anastrozole
L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors

Trade names

Trade name
Countries
AMENUR

Spain

ANASTROL

Australia

ANASTROLAN

Austria

ANESTRA

Singapore

ANEXTROZOLE

Singapore

ANZONAT

Singapore

AREMED

Cyprus Singapore

ARIANNA 1

Australia

ARIMIDEX

Australia Austria Canada Cyprus France

AROMATT

Singapore

FEMIZET

Singapore

STRAZOLAN

Cyprus

VALEX

Cyprus

Product Monographs

Monograph
Type
Country
ARIMIDEX Film-coated tablets
MPI, EU: SmPC
UK

2D Molecule Structure

3D Molecule Structure

Unique Ingredient Identifier (UNII)

2Z07MYW1AZ - ANASTROZOLE

CAS Registry Number

120511-73-1 - anastrozole

SNOMED-CT

386910003 - Anastrozole (substance)

 
Next: Usage >